GH · Guardant Health Inc
United States · RS rating 88 · As of 2026-11-03
| Price | 175.00 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 42 / 79 / 93 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 50 / 77 / 32 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | -35.1% |
| Sales growth Q/Q | +6.1% |
| Distance from 52-week high | +6.5% |
| Market cap (USD) | $11.5B |